
New generation in weight-loss therapies targets overweight
Oxford Medical Products (OMP) has announced additional three-month clinical trial results for Sirona, its weight-loss treatment targeting people who are overweight or have class I obesity (BMI 25-35) and those transitioning off GLP-1 medication. The clinical trial took place across three NHS hospitals in the UK and… Read More
